Insmed INSM
NASDAQ INSM
$126.31 -0.37 (-0.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Insmed (INSM) Gross Margin (2018 - 2026)

Insmed (INSM) posted quarterly Gross Margin of 84.5% for Q1 2026, up 742.0% year-over-year from 10.04% in Q1 2025, and up 1.52% quarter-over-quarter from 83.24% in Q4 2025.

Analysis

Insmed (INSM) Gross Margin (2018 - 2026) Analysis & Trends

Insmed's Gross Margin history runs 9 years deep, the most recent figure standing at 84.5% for Q1 2026.

  • In Q1 2026, Gross Margin rose 742.0% year-over-year to 84.5%; the TTM figure through Mar 2026 stood at 81.81% (up 532.0% YoY), while the FY2025 annual figure was 79.73%, up 330.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 84.5%, up from 83.24% in the prior quarter.
  • The five-year high for Gross Margin was 84.5% in Q1 2026, with the low at 73.86% in Q2 2025.
  • The 5-year median for Gross Margin is 77.96% (2022), against an average of 78.13%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin plunged 300 bps in 2024, then surged 828 bps in 2025.
  • Insmed's Gross Margin stood at 77.96% in 2022, then gained by 0 bps to 77.96% in 2023, then retreated by 4 bps to 74.96% in 2024, then rose by 11 bps to 83.24% in 2025, then rose by 2 bps to 84.5% in 2026.
  • Business Quant data shows INSM's Gross Margin at 84.5% in Q1 2026, 83.24% in Q4 2025, and 79.37% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 91.59%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 90.43%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 35.86%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 89.76%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 76.90%
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 84.20%
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 93.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 84.20%
Mar 31, 2026 84.50%
Dec 31, 2025 83.24%
Sep 30, 2025 79.37%
Jun 30, 2025 73.86%
Mar 31, 2025 77.08%
Dec 31, 2024 74.96%
Sep 30, 2024 77.34%
Jun 30, 2024 76.79%
Mar 31, 2024 76.88%
Dec 31, 2023 77.96%
Sep 30, 2023 78.87%
Jun 30, 2023 78.51%
Mar 31, 2023 78.79%
Dec 31, 2022 77.96%
Sep 30, 2022 80.11%
Jun 30, 2022 74.86%
Mar 31, 2022 77.04%
Dec 31, 2021 76.32%
Sep 30, 2021 78.22%